In a filing, Bicycle Therapeutics Plc ADR revealed its CHIEF EXECUTIVE OFFICER Lee Kevin unloaded Company’s shares for reported $23756.0 on Jul 03 ’25. In the deal valued at $7.44 per share,3,193 shares were sold. As a result of this transaction, Lee Kevin now holds 480,804 shares worth roughly $4.02 million.
Then, Lee Kevin sold 2,268 shares, generating $16,080 in total proceeds. Upon selling the shares at $7.09, the CHIEF EXECUTIVE OFFICER now owns 483,997 shares.
Before that, Skynner Michael sold 966 shares. Bicycle Therapeutics Plc ADR shares valued at $7,187 were divested by the CHIEF TECHNOLOGY OFFICER at a price of $7.44 per share. As a result of the transaction, Skynner Michael now holds 120,079 shares, worth roughly $1.01 million.
Stephens initiated its Bicycle Therapeutics Plc ADR [BCYC] rating to an Equal-weight in a research note published on November 08, 2024; the price target was $25. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in early September with a ‘”an Outperform”‘ rating. B. Riley Securities also remained covering BCYC and has decreased its forecast on August 07, 2024 with a “Neutral” recommendation from previously “Buy” rating. B. Riley Securities revised its rating on September 11, 2023. It rated BCYC as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BCYC
On Tuesday, Bicycle Therapeutics Plc ADR [NASDAQ:BCYC] saw its stock jump 0.72% to $8.37. Over the last five days, the stock has gained 8.98%. Bicycle Therapeutics Plc ADR shares have fallen nearly -62.92% since the year began. Nevertheless, the stocks have fallen -40.21% over the past one year. While a 52-week high of $28.67 was reached on 01/07/25, a 52-week low of $6.10 was recorded on 04/09/25.
Levels Of Support And Resistance For BCYC Stock
The 24-hour chart illustrates a support level at 8.15, which if violated will result in even more drops to 7.93. On the upside, there is a resistance level at 8.64. A further resistance level may holdings at 8.92.
How much short interest is there in Bicycle Therapeutics Plc ADR?
A steep rise in short interest was recorded in Bicycle Therapeutics Plc ADR stocks on 2025-06-30, dropping by -0.85 million shares to a total of 2.6 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 3.45 million shares. There was a decline of -32.85%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 31, 2022 when Cowen began covering the stock and recommended ‘”an Outperform”‘ rating .
